← Back to Clinical Trials
Recruiting NCT06605001

NCT06605001 Development, Attention, and Inhibition Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06605001
Status Recruiting
Phase
Sponsor University of California, Davis
Condition The Ability to Delay Gratification
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2024-08-21
Primary Completion 2026-12-31

Trial Parameters

Condition The Ability to Delay Gratification
Sponsor University of California, Davis
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 4 Years
Max Age 7 Years
Start Date 2024-08-21
Completion 2026-12-31
Interventions
Delay of Gratification

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to test the associations of young children's early life experiences with delaying behaviors and links with later life outcomes. The main questions it aims to answer are: * Do experiences with waiting in early childhood predict delaying behavior in context-specific ways? * Are links between delaying behavior and life outcomes impacted by social conventions, effort and choices around delaying, or other behaviors? Participants will: * Complete two delaying tasks with either a sweet or wrapped gift * Complete three "Simon says"-like games that measure inhibition, cognitive flexibility and proactive control * Answer a set of questions about academic readiness * Answer a set of questions about social conventions * Complete a waiting game on the computer while a camera records eye movements * Parents will answer questions about their child's behaviors and experiences at home * Participants will return after 1 year to repeat a subset of these measures

Eligibility Criteria

Typically developing children will be recruited. Participants will be pre-screened for developmental disorders.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology